日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies

血浆衍生物溶剂/洗涤剂处理的稳健性:来自血浆蛋白治疗协会成员公司的数据收集

Dichtelmüller, Herbert O; Biesert, Lothar; Fabbrizzi, Fabrizio; Gajardo, Rodrigo; Gröner, Albrecht; von Hoegen, Ilka; Jorquera, Juan I; Kempf, Christoph; Kreil, Thomas R; Pifat, Dominique; Osheroff, Wendy; Poelsler, Gerhard

Ensuring the biologic safety of plasma-derived therapeutic proteins: detection, inactivation, and removal of pathogens

确保血浆衍生治疗性蛋白的生物安全性:病原体的检测、灭活和去除

Cai, Kang; Gierman, Todd M; Hotta, JoAnn; Stenland, Christopher J; Lee, Douglas C; Pifat, Dominique Y; Petteway, Steve R Jr

Inactivation of West Nile virus, vaccinia virus and viral surrogates for relevant and emergent viral pathogens in plasma-derived products

血浆衍生产品中西尼罗病毒、牛痘病毒以及相关和新出现的病毒病原体的病毒替代物的灭活

Remington, K M; Trejo, S R; Buczynski, G; Li, H; Osheroff, W P; Brown, J P; Renfrow, H; Reynolds, R; Pifat, D Y